Magnetic muon measurements and gene-therapy advances win US$3 million Breakthrough prizes
Briefly

Magnetic muon measurements and gene-therapy advances win US$3 million Breakthrough prizes
"The results seemingly confirm the standard model of particle physics, but team member David Hertzog says that it is not yet 'game over', with mysteries remaining around why two independent methods used to calculate the model's predictions disagree drastically."
"It is astonishing that human beings can measure anything to such precision, says Tsutomu Mibe, a particle physicist at Japan's High Energy Accelerator Research Organization."
"The prize will be shared by the several hundred collaborators who were involved in the experiments at CERN, Brookhaven National Laboratory, and Fermilab."
"Opthalmologists Jean Bennett and Albert Maguire, and physician Katherine High were recognized for developing Luxturna, the first FDA-approved gene-augmenting therapy."
Researchers measuring the magnetic properties of the muon particle have won a US$3 million Breakthrough prize. Their results confirm the standard model of particle physics, yet discrepancies remain in predictions from two independent calculation methods. The final results of the muon's magnetic moment measurements were announced by Fermilab, showing a precision of 127 parts in a billion. The prize will be shared among several hundred collaborators from various laboratories. Additionally, three life-science prizes were awarded for advances in gene therapies, including the development of Luxturna, the first FDA-approved gene-augmenting therapy.
Read at Nature
Unable to calculate read time
[
|
]